Tokyo, June 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061317) titled 'A study on intraocular diffusion following intravenous administration of gadolinium-based contrast agents in patients with glaucoma' on June 1.
Study Type:
Observational
Primary Sponsor:
Institute - Nagoya University
Condition:
Condition - Glaucoma
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to elucidate the relationship between the ocular glymphatic system and glaucoma. By doing so, it may provide new insights into intraocular aqueous humor dynamics and clarify the potential involvement of the glymphatic system in the pathophysiology of glaucoma.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Glaucoma patient
Key exclusion criteria - Patients with hypersensitivity or allergy to gadolinium-based contrast agents
Patients with severe renal impairment or those on dialysis
Pregnant patients
Breastfeeding patients
Patients with asthma
Patients who are unable to undergo MRI examination
Patients with claustrophobia
Target Size - 80
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 04 Month 20 Day
Anticipated trial start date - 2026 Year 06 Month 01 Day
Last follow-up date - 2028 Year 05 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070127
Disclaimer: Curated by HT Syndication.
